Name:
|
DILTIAZEM (CardizemR)
|
Classification: |
calcium channel blocker
- prolongs the refractory periods of the AV node and intranodal conduction
- provides temporary control of rapid ventricular rate in atrial fibrillation and atrial flutter, but rarely converts to normal sinus rhythm
- may provide rapid conversion of paroxysmal supraventricular tachycardias to sinus rhythm
- has been used as intracoronary injection to prevent vasospasm during coronary angioplasty
- used post radial artery coronary bypass graphs to prevent spasm
|
Dose: |
- Bolus:
- 0.1-0.3mg/kg IV direct over 2 minutes
- a subsequent dose of 0.35mg/kg may be administered after 15 minutes if the initial response is inadequate
- Infusion:
- 5-10 mg/h immediately following direct injection
- may be increased by 5 mg/h to a maximum of 15mg/h to achieve target
- Intracoronary:
|
Administration: |
IV Infusion:
dilute 125 mg in 100ml dextrose 5% or sodium chloride 0.9% (1 mg/ml)
|
Adverse Effects: |
- hypotension, decreased SVRI
- decreased cardiac output
- arrhythmias
- bradycardia
- AV block
- prolonged QT
- flushing
- dizziness
- dyspnea
- headache
|
Caution: |
- contraindicated in patients with hypotension, sick sinus syndrome, second and complete AV block, and in patients with acute myocardial infarction and pulmonary edema
- use cautiously in patients with AV conduction delays or transient sinus pauses
|
Drug Interactions: |
- diltiazem + beta blockers = decreased HR, CI and prolonged PR interval
- diltiazem + digoxin = increased digoxin plasma concentrations
- diltiazem + cyclosporin = increased cyclosporin plasma concentrations
- diltiazem + amiodardone = increased diltiazem plasma concentrations
- diltiazem + cisapride = prolonged QT with Torsades de Pointes
|
Monitoring Therapy: |
- continuous heart rate and rhythm
- PR interval and QT interval
- blood pressure
- urine output
- central or mixed venous oxygen saturation
- lacate
- breath sounds
|
Adult Critical Care Protocol: |
- May be administered IV direct or by IV infusion by an approved nurse in CCTC.
- Continuous infusion must be administered via an infusion pump.
- Patient requires placement of an arterial line to monitor BP if intravenous infusion is used.
|